C12N 2760/18461
Methods of inactivation or attenuation
C12N2760/18461 (Methods of inactivation or attenuation) appears on 20 US grants and 17 published applications in this corpus.
Search patents in C12N- Granted patents
- 20
- Published applications
- 17
- Assignees
- 30
- Inventors
- 57
- Latest grant
- 17 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 2 | 2 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 3 |
| 2019 | 1 | 0 |
| 2020 | 2 | 2 |
| 2021 | 1 | 0 |
| 2022 | 1 | 1 |
| 2023 | 1 | 1 |
| 2024 | 1 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Modulation of replicative fitness by deoptimization of synonymous codons17 Sep 2024US 12,090,197 B2The Government of the USA, as represented by the Secretary, Department of Health and Human Services
- Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus30 May 2023US 11,660,337 B2Liaoning Yikang Biological Corporation Limited
- Modulation of replicative fitness by deoptimization of synonymous codons15 Nov 2022US 11,497,803 B2The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
- Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy20 Apr 2021US 10,980,873 B2Centre National de la Recherche Scientifique (CNRS)
- Tunable vaccine platform against pathogens of the paramyxovirus family22 Sep 2020US 10,780,158 B2Georgia State University Research Foundation, Inc.
- Recombinant measles virus5 Sep 2024US 2024/0293533 A1
- Modulation of replicative fitness by deoptimization of synonymous codons31 Aug 2023US 2023/0270833 A1The Government of the U.S.A. as represented by the Secretary of the Dept. of Health & Human Services
- Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus21 Apr 2022US 2022/0118083 A1Liaoning Yikang Biological Corporation Limited
- Modulation of replicative fitness by deoptimization of synonymous codons27 Aug 2020US 2020/0268865 A1The Government of the U.S.A. as represented by the Secretary of the Dept. of Health & Human Services
- Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (mv-deltac virus) in cancer therapy16 Jan 2020US 2020/0016260 A1Centre National De La Recherche Scientifique
Most cited
By later US patents
- Modified Morbillivirus V proteins65US 6,664,066 B2Wyeth Holdings Corporation · 2003
- Method for inactivating a virus36US 5,891,705 APentose Pharmaceuticals, Inc. · 1999
- Modulation of replicative fitness by deoptimization of synonymous codons20US 8,846,051 B2The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · 2014
- Process for production of vaccines14US 3,933,585 AMerck & Co., Inc. · 1976
- Combined vaccine against both HAV and measles virus and method of producing it12US 6,562,350 B1Changchun Institute of Biological Products, Ministry of Public Health · 2003